Skip to content
★ Sign in to follow
Total declarations
2
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 13 Oct 2026 for Cue Biopharma, Inc., €272k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

Shao-Lee Lin: trading record in brief

This profile gathers the share dealings of Shao-Lee Lin in Cue Biopharma, Inc. We count 2 filings; the first trade dates from 12 August 2026 and the latest from 12 October 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Most recently, on 13 October 2026, the filings show a transaction worth €272k in Cue Biopharma, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Shao-Lee Lin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ●
    Officer, DirectorExecutivesCue Biopharma, Inc.
    305,490 USD0Source
    11,087 shares@ US$27.5539Common StockSEC144:0001725092-26-000017
  • ●
    Officer, DirectorExecutivesCue Biopharma, Inc.
    2M USD35Source
    58,258 shares@ US$27.40170.69% mcap100.0% of flowCommon StockSEC144:0001725092-26-000011

2 of 2 declarations